NCT01458210View on ClinicalTrials.gov

A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Ortho-Cyclen

Administered orally

BIOLOGICAL

Dulaglutide

Administered subcutaneously

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01458210 - A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants | Biotech Hunter | Biotech Hunter